Clinicopathologic characteristics of immune colitis in melanoma patients treated with combination ipilimumab and anti-PD1 (IPI+PD1) and PD1 monotherapy

被引：0

作者：

Nahar, K. J. ^{[1
]}

Rawson, R. V. ^{[2
]}

Sandanayake, N. ^{[3
]}

Tattersal, S. ^{[3
]}

Carlino, M. S. ^{[4
,5
,6
]}

Palendira, U. ^{[7
]}

Scolyer, R. A. ^{[8
,9
]}

Long, G. V. ^{[10
,11
]}

Menzies, A. M. ^{[10
,11
]}

机构：

[1] Univ Sydney, Cent Clin Sch, Camperdown, NSW, Australia

[2] Royal Prince Alfred Hosp, Anat Pathol, Camperdown, NSW, Australia

[3] Royal North Shore Hosp, Gastroenterol, St Leonards, NSW, Australia

[4] Westmead Hosp, Med, Melanoma Inst Australia, Sydney, NSW, Australia

[5] Blacktown Hosp, Med, Melanoma Inst Australia, Sydney, NSW, Australia

[6] Univ Sydney, Sydney, NSW, Australia

[7] Univ Sydney, Med, Camperdown, NSW, Australia

[8] Univ Sydney, Melanoma Inst Australia, Med, Sydney, NSW, Australia

[9] Royal Prince Alfred Hosp, Sydney, NSW, Australia

[10] Univ Sydney, Mater Hosp, Melanoma Inst Australia, Med, Sydney, NSW, Australia

[11] Royal North Shore Hosp, Sydney, NSW, Australia

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1351P

引用

页码：552 / 552

页数：1